Table 2.
Surgical data for all methods of breast tumour localization.
| Intervention (Number of Trials) | Number (%) | Positive margins (%) | Reoperation rates (%) | Operation Time in minutes (SD) | Complications (%) | Haematoma (%) | Seroma (%) | SSI (%) |
|---|---|---|---|---|---|---|---|---|
| WGL (24) | 2045 (48.3%) | 411 (20.1%) | 239/1379 (17.3%) | 42.1 (13.2) | 59/842 (7.0%) | 11/594 (1.9%) | 14/511 (2.7%) | 20/522 (3.8%) |
| USG (3) | 316 (7.5%) | 17 (5.4%) | 14/289 (4.8%) | 73.0 (17.5) | – | – | – | – |
| ROLL (10) | 640 (15.1%) | 110 (17.2%) | 37/379 (9.8%) | 28.0 (9.7) | 24/478 (4.6%) | 11/384 (2.9%) | 7/283 (2.5%) | 13/387 (3.4%) |
| RSL (6) | 845 (20.0%) | 99 (11.7%) | 71/689 (10.3%) | 19.0 (9.0) | 31/359 (8.6%) | 6/163 (3.7%) | 5/207 (2.4%) | 6/207 (2.9%) |
| ML (1) | 32 (0.8%) | 2 (6.3%) | 1/32 (3.1%) | 54.0 (14) | 4/32 (12.5%) | 1/32 (3.1%) | 2/32 (6.3%) | 1/32 (3.1%) |
| IL (1) | 32 (0.8%) | 4 (12.5%) | – | 31.0 (5.0) | – | – | – | – |
| CAL (1) | 206 (4.9%) | 58 (28.2%) | 39/206 (18.9%) | 31.0 | ||||
| AGL (1) | 52 (1.2%) | 5 (9.6%) | 5/52 (9.6%) | 9.7 | ||||
| SMRI (1) | 68 (1.6%) | 8 (11.8%) | 8/68 (11.8%) | – | – | – | – | – |
| Total (24) | 4236 (100.0%) | 714 (16.9%) | 409/2870 (14.3%) | Mean: 38.4 (12.3) | 116/1711 (6.8%) | 25/1217 (2.1%) | 28/1033 (2.7%) | 40/1226 (3.3%) |
SD; standard deviation, SSI; surgical site infection, WGL; wire-guided localization, USGL; ultrasound-guided localization, ROLL; radio-guided occult lesion localization, RSL; radioactive seed localization, ML; magnetic-marker localization, IL; indocyanine green fluorescence-guided lumpectomy, CAL; cryo-assisted localization, AGL; anchor-guided localization, SMRI; intraoperative supine magnetic resonance imaging.